EurekAlert! -
12 May 2021 06:00
(Massachusetts General Hospital) Previous research has suggested that an inhaled anesthetic called sevoflurane may promote the brain changes of Alzheimer's disease. A new study in cells and mice reveals that sevoflurane causes the Alzheimer's-related protein tau to leave neurons and enter immune cells (microglia) in the brain, ultimately leading to inflammation and cognitive impairment.
Share this Article